Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Cell Death & Disease logoLink to Cell Death & Disease
. 2021 Mar 3;12(3):232. doi: 10.1038/s41419-021-03420-5

Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer

Lusheng Wei 1,2,#, Huilin Ye 1,2,#, Guolin Li 1,2,#, Yuanting Lu 3, Quanbo Zhou 1,2, Shangyou Zheng 1,2, Qing Lin 1,2, Yimin Liu 1,4, Zhihua Li 1,5,, Rufu Chen 1,2,
PMCID: PMC7930264  PMID: 33658480

Correction to: Cell Death & Disease

10.1038/s41419-018-1104-x published online 18 October 2018

Since online publication of this article, the authors noticed errors in Figs. 6C and 9A. In 6C an incorrect image was used for the primary image of “CAF-P4 FAP”. In Fig. 9A, incorrect brightness and scale were used for the SDF-1 ‘Low’ and ‘High’ images, respectively. The authors apologise for these errors. The corrected images are provided below.

graphic file with name 41419_2021_3420_Fig1_HTML.jpg

Fig. 6.

graphic file with name 41419_2021_3420_Fig2_HTML.jpg

Fig. 9.

Footnotes

Edited by S. Tait

These authors contributed equally: Lusheng Wei, Huilin Ye, Guolin Li.

Contributor Information

Zhihua Li, Email: zhihuali_sysu@163.com.

Rufu Chen, Email: chenrufu63@163.com.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES